Hélène Sapin

Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial

Baptist Gallwitz, Juan M. Sánchez‐Guzmán, Francesco Dotta et al. · The Lancet · 2012 · 156 citations

Metabolic Syndrome, Diabetes Management, Versus Glimepiride +10

Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort

M. Lukasiewicz, Stéphanie Gerard, Adeline Besnard et al. · International Journal of Methods in Psychiatric Research · 2013 · 119 citations · Full text

Psychopathology, Psychiatric Evaluation, Mental Health +20

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir

Melanie J. Davies, Simon Heller, Séamus Sreenan et al. · Diabetes Care · 2012 · 82 citations · Full text

Genotypes and Phenotypes of Children with SHOX Deficiency in France

Myriam Rosilio, Céline Huber, Hélène Sapin et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 67 citations · Full text

Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison

Karan Vadher, Hiren Patel, Reema Mody et al. · Diabetes Obesity and Metabolism · 2022 · 51 citations · Full text